NCT01586975View on ClinicalTrials.gov

Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

April 30, 2010

Study Completion Date

December 31, 2011

Conditions
StrokeMyocardial Infarctions
Interventions
DRUG

Clopidogrel

Clopidogrel 75 mg QD

DRUG

Aspirin 81 mg

Aspirin 81mg QD

DRUG

Aspirin >300 mg

Aspirin \>300 mg QD

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT01586975 - Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events | Biotech Hunter | Biotech Hunter